Clinical Trials in Cleveland

Showing 2381-2400 of 19,775 trials

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

NCT02833610

This research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.

Multiple Myeloma

Massachusetts General Hospital55 participantsStarted Aug 2016

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +4 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05057494

A study of acalabrutinib plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

AstraZeneca607 participantsStarted Sep 2022

Tucson, Arizona, United States • La Jolla, California, United States • Longmont, Colorado, United States +35 more locations

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Find Trials by Condition in Cleveland

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)

A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum

Longitudinal Early-onset Alzheimer's Disease Study Protocol

GORE® ENFORM Biomaterial Product Study

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors